CIA
Capital Impact Advisors’s Karyopharm Therapeutics KPTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-153,449
| Closed | -$1.4M | – | 130 |
|
|
2019
Q1 | $1.4M | Hold |
153,449
| – | – | 0.62% | 93 |
|
|
2018
Q4 | $1.4M | Buy |
153,449
+51,443
| +50% | +$470K | 0.6% | 96 |
|
|
2018
Q3 | $1.74M | Buy |
+102,006
| New | +$1.74M | 0.6% | 93 |
|
|
2016
Q3 | – | Sell |
-11,662
| Closed | -$78K | – | 221 |
|
|
2016
Q2 | $78K | Hold |
11,662
| – | – | 0.04% | 219 |
|
|
2016
Q1 | $104K | Hold |
11,662
| – | – | 0.05% | 219 |
|
|
2015
Q4 | $155K | Hold |
11,662
| – | – | 0.07% | 250 |
|
|
2015
Q3 | $123K | Hold |
11,662
| – | – | 0.06% | 252 |
|
|
2015
Q2 | $317K | Hold |
11,662
| – | – | 0.14% | 230 |
|
|
2015
Q1 | $357K | Buy |
11,662
+7,843
| +205% | +$240K | 0.16% | 224 |
|
|
2014
Q4 | $143K | Hold |
3,819
| – | – | 0.07% | 181 |
|
|
2014
Q3 | $133 | Hold |
3,819
| – | – | ﹤0.01% | 175 |
|
|
2014
Q2 | $178K | Buy |
+3,819
| New | +$178K | 0.13% | 111 |
|